MIRM
MIRM
NASDAQ · Biotechnology

Mirum Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$107.77
+0.64 (+0.60%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -38.1% upside
Low Target $36.90
Average Target $66.73
High Target $76.87
Current Price $107.77
Current
$107.77
Target
$66.73
$36.90 $66.73 avg $76.87
Scenario Analysis
Bear Case
$36.90
-65.8%
Low target
Base Case
$66.73
-38.1%
Avg target
Bull Case
$76.87
+-28.7%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$114.99
-6.3% from high
52-Week Low
$47.89
+125.0% from low
50-Day SMA
$87.61
+23.0% vs SMA
200-Day SMA
$68.12
+58.2% vs SMA
RSI (14)
56.6
Neutral
Target vs 52W High
$66.73
-42.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%